Shawn Defrees

Neurosant Therapeutics LLC

NIH Rank #46813
  • Early Career

NIH Funding · FY2024

Total Funding
$189.1K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#46,813
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $189.1K across 1 grant · National rank #46813.

Top grants by award amount

Shawn Defrees's NIH grant portfolio, ranked by award amount.

  • 1R21HD115076-01R21
    Therapeutics that Correct the Underlying Cause of Smith-Magenis Syndrome (SMS)
    $189.1K
    award amount

Affiliation

Institutions that have administered grants for Shawn Defrees.

Affiliated with Neurosant Therapeutics LLC (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Neurosant Therapeutics LLC

Related investigators

Other NIH-funded PIs frequently associated with Shawn Defrees.